Cystic Schwannoma Of cavernous Sinus in a middle aged lady presenting with headache and 3rd nerve palsy
** Click to view the case in a new browser
Guideline for the KSIR (Korean Society of Interventional Radiology) International Fellowship
The objectives of the fellowship are to promote clinical activity by Asian specialists in interventional radiology and to train them in Korean academic institutions. And it is also to contribute to the distribution and improvement of interventional radiology in Asia, encouraging mutual understanding as well as scientific cooperation.
- Administration of the Fellowship
The fellowship will be administered under the rules of KSIR Fellowship as decided at KSIR. KSIR will be responsible for the following matters regard to clinical training in Korea: 1) Selection of Participant. 2) Assistance in finding an appropriate institution for the candidate. 3) Giving a grant for the fellowship. 4) Issue of certificate in completion of clinical training after receiving a related report from the recipient.
- Institutions for Clinical Training
National, public or private institutions in Korea, including universities, colleges, hospitals, laboratories(etc.) which are able to receive Participant.
- Terms and Period for Clinical Training
(1) The terms for clinical training and/or research shall be from 1 month to 3 months in principle. (2) The period of clinical training and/or research shall not be altered in principle. (3) The Participant must start the training in their applicable year. (4) The due date for the application is May 24th every year and applicants are given an official notification during June from KSIR. (5) Prerequisite: The Participant should attend IICIR (International Intensive Course of Interventional Radiology) meeting before or during their fellowship training period in Korea. 2016 IICIR will be held in Seoul next year (Feb 22th ~ 26th).
- Field of Clinical Training and/or Research
Clinical training and/or research shall be in the field of interventional radiology.
- Requirements of Participant
(1) Age: Participant may be up to 40 years of age. (2) Career: Participant must be specialists with sufficient training and experience in radiology who have graduated from medical colleges. (3) Language: Participant must use fluent English to enable them to complete the clinical training (If you have any certificate-credit- of TOEFL or TOEIC, please send it with other documents)
- Duties of Participant
(1) During the period of clinical training, Participant must obey Korean law, should cooperate with teachers and related personnel, and should make every effort to achieve the objectives of the fellowship. (2) On completion of the period of clinical training, Participant should submit a related report to the office of KSIR at their earliest convenience. (3) Immediately on completion of clinical training, Participant are obliged to leave Korea for their home country where they should contribute to the general improvement of interventional radiology.
- Grant for Recipient
KSIR sponsors for Asian radiologist who would like to spend as visiting fellow in Korea. The grant will include air-fare and minimum cost of living (30,000 KRW per day). Some hospitals have their own guest house with low price for visiting fellows, but you may check a vacant room and make a reservation.
- Documents for submission
– Application form – Reference from director (including your English level) Please send to KSIR Office via Email E-mail: firstname.lastname@example.org Fax: +82-2-2227-8037 http://www.intervention.or.kr Indian Radiological & Imaging Association IRIA House, C-5, Qutab Institutional Area Behind Qutab Hotel New Delhi-110 016 Tel. 011-26965598, 41688846 Fax: 011-26565391 E-mail: email@example.com Website: www.iria.in
Multiple Sclerosis Continue reading
Abstract of paper presented in Asia Pacific Congress for Study of Liver (APASL,2004,N.Delhi)
HEPATO CELULLAR CARCINOMA : MULTIPHASIC CT EVALUATION IN 27 PATIENTS
H. S. Das, N. Medhi, P. K. Sarma, P. Goswami, P. Hazarika, B. Sarma
Primus Imaging, G. S. Road
Hepato cellular carcinoma ( HCC) is the eight most common malignancy worldwide and represents 6 % of all tumors. It is also the most common primary hepatic malignancy. Increased incidence of HCC is seen in the Far East, Southeast Asia and sub-Saharan Africa ( 90 cases per 1,00,000 population versus 2.4 cases per 100,000 in the United States.
Risk factors for developing HCC includes cirrhosis, hepatitis B and C viruses. Additional risk factors include haemochromatosis, excessive androgens, ∞ 1 antitrypsin deficiency, exposure to oral contraceptives, Thorotrast, aflatoxins and vinyl chloride. Hepatitis B is considered to be the primary cause in 80% of cases worldwide. Peak age of incidence is 50 to 70 yrs with a male predominance of 4:1.
Objective :- To evaluate clinical and multiphasic helical CT findings in 27 patients of hepato cellular carcinomas.
Materials and Methods :- Multiphasic helical CT scans were performed in 27 patients of HCC’s. Non ehanced scans were obtained in all patients, along with hepatic arterial dominant phase ( HAP) and portal venous dominant phase (PVP) images at 25-28 and 60-70 seconds after intravenous infusion of 60 to 80 ml of contrast. Delayed sections were also obtained in all the patients after 5 to 10 minutes. We reviewed age, gender, tumor risk factor, serum tumor markers, and tumor morphology with degree and type of enhancement on helical multiphasic CT.
Results : – 22 of the 27 patients ( 81% ) were men. Patients had an age range of 30 to 87 yrs ( mean = 55.9 years ). Abdominal signs and symptoms were present in 25 out of 27 patients ( 92.5 %) and 11 of 27 patients( 40.7 %) had chronic liver disease ( CLD). Abdominal signs and symptoms were present in 24 of 27 patients HCC was proved on the basis of Biopsy (n= 16 ) and by levels of increased serum alpha feto-protein (n=19 ). 15 patients had solitary or dominant mass. At CT well defined tumor was demonstrated in all the patients with signs of malignancy with hepatic hypervascularity ( 96 %), biliary obstruction (10%),satellite lesions (45%) , lymphadenopathy ( 25 %), ascites (18 % ) and
portal venous thrombosis in 11 %. Portions of tumors were heterogeneously hyperattenuating at arterial phase in 27 (100%) and hypoattenuating in portal phase in 24 patients (88 %). Some of the larger tumors showed delayed persistent enhancement in the equilibrium phase (n= 6 ). Most of the tumors were hypoattenuating on the unenhanced images.
Conclusion: In our patients HCC was seen to develop in presence and absence of cirrhosis or known risk factors and typically appeared as large, symptomatic hepatic masses with clinical, laboratory and CT features that helps to identify these tumors from other hepatic masses.